Related content

Effect of risedronate on biochemical marker of bone resorption in postmenopausal women with osteoporosis or osteopenia

By Dane Cem   Dane Banu   Cetin Ahmet   Erginbas Murat  

Gynecological Endocrinology, Vol. 24, Iss. 4, 2008-01 ,pp. : 207-213

Informa Healthcare

Access to resources Recommend Favorite

Evidence that Treatment with Risedronate in Women with Postmenopausal Osteoporosis Affects Bone Mineralization and Bone Volume

By Fratzl Peter   Roschger Paul   Fratzl-Zelman Nadja   Paschalis Eleftherios   Phipps Roger   Klaushofer Klaus  

Calcified Tissue International, Vol. 81, Iss. 2, 2007-08 ,pp. : 73-80

Springer Publishing Company

Access to resources Recommend Favorite

Effect of Risedronate on Osteocyte Viability and Bone Turnover in Paired Iliac Bone Biopsies from Early Postmenopausal Women

By Qiu S.  

Calcified Tissue International, Vol. 87, Iss. 5, 2010-11 ,pp. : 392-397

Springer Publishing Company

Access to resources Recommend Favorite

Risedronate Rapidly Reduces the Risk for Nonvertebral Fractures in Women with Postmenopausal Osteoporosis

By Harrington J. T.  

Calcified Tissue International, Vol. 74, Iss. 2, 2004-04 ,pp. : 129-135

Springer Publishing Company

Access to resources Recommend Favorite

Serum lipid levels and bone mineral density in Greek postmenopausal women

By Pliatsika Paraskevi   Antoniou Aris   Alexandrou Andreas   Panoulis Constantinos   Kouskouni Evangelia   Augoulea Areti   Dendrinos Spyridon   Aravantinos Leon   Creatsa Maria   Lambrinoudaki Irene  

Gynecological Endocrinology, Vol. 28, Iss. 8, 2012-08 ,pp. : 655-660

Informa Healthcare

Access to resources Recommend Favorite